m O placentae are hyperplastic. This finding suggested that the hyperplasia might be an X dosage effect, and this hypothesis was supported by the finding that XY male fetuses from the same crosses also had larger placentae than their XX sibs. Further analysis of a range of sex-chromosome variant genotypes, including X m YSry-negative females and XXSry transgenic males, showed that mouse fetuses with one X chromosome consistently had larger placentae than littermates with two X chromosomes, independent of their gonadal/androgen status. developmental biology, embryo, placenta, pregnancy, trophoblast
INTRODUCTION
In the early 1980s, it became possible to efficiently generate X p O mice (mice with a paternally derived X chromosome) by using females heterozygous for the large X inversion, In(X)1H [1] , but it was not until the 1990s that X m O mice (with a maternally derived X chromosome) could also be routinely generated by using males carrying the patchy fur (Paf) mutation [2] . Studies of the development of these X p O and X m O mice have revealed that paternal X monosomy leads to retardation of embryonic development by approximately 5.5 h relative to X m O embryos [3] [4] [5] . At egg cylinder stages, X p O embryos also have a smaller ectoplacental cone, even after allowing for the developmental retardation [6] . Incidental to their study of X p O development, Burgoyne et al. [3] also measured placental weights and found that late in pregnancy the placen- The ectoplacental cone is thought to give rise predominantly to the spongiotrophoblast of the placenta [7] , which constitutes approximately 30% of the volume of the placenta in late pregnancy [8] . We have previously observed an increase in spongiotrophoblast tissue in 13.5 days postcoitum (dpc) X p O placentae [9] . This finding suggests that enlargement of X p O placentae in late gestation could be a consequence of a compensatory response to initial ectoplacental cone deficiency. In this study, we investigated further XO placental size in mice in late pregnancy to determine whether hyperplasia was correlated with early ectoplacental cone deficiency of X p O but not X m O embryos.
MATERIALS AND METHODS

Mice
We utilized four mouse strain crosses. All mice were bred on a randombred MF1 albino (National Institute for Medical Research colony) background.
1. In(X)/X ϫ XY RIII . The females in this cross are heterozygous for the In(X)1H inversion [1] . Although fully backcrossed to MF1, the inversion retains its C3H strain origin because crossing over within the inversion leads to loss of the recombinant products and the associated production of nullo-X eggs. For reasons unrelated to this study, the males in this cross carry a Y chromosome originating from the RIII inbred strain [10] . This is the cross originally used by Burgoyne et al. [3] to generate X p O conceptuses.
2. XX ϫ XY*. The males in this cross carry the variant Y* chromosome that has a compound pseudoautosomal region (PAR) together with a non-Y centromere distal to the PAR [11] [12] [13] . This cross produces a low frequency of X m O conceptuses together with XX, XY*, XY* X , and XX Y * conceptuses (Y* X and X Y * are the very small and large products of recombination between the X and Y* [12, 13] ). We did not use the more efficient XX ϫ X Paf Y* cross [14] because the Paf mutation affects placental size (unpublished data).
3. XX ϫ X Y *O. The males in this cross carry the X Y * recombinant product originating from Y*. Although males of this genotype are normally sterile [15] , we have been able to establish an exceptional pedigree of these males from which a proportion of fertile X Y *O males is generated (unpublished results). This cross produces X m O and XX Y * conceptuses.
XX ϫ XY
Tdym1
Sry. Y Tdym1 (hereinafter abbreviated as Y Ϫ ) has a deletion removing the testis determinant Sry, and this deletion has been complemented by an autosomally located Sry transgene [16, 17] . This cross generates XX and XY Ϫ female conceptuses and XXSry and XY Ϫ Sry male conceptuses.
Genotyping
Where necessary, XO, XY* X , and XX Y * conceptuses were identified from metaphase spreads obtained from fetal liver [18] . Other genotypes were established using the following PCR assays on DNA obtained from yolk sac.
1. In(X)1H. The In(X)1H inversion originated on a C3H/He X chromosome, and although we have back-crossed this inversion to a randombred MF1 background, the inverted segment has remained C3H because crossing over within the inverted segment leads to loss of the recombinant products [19] . We have therefore identified inversion carriers by PCR for Planned comparisons for the first three crosses are those involving XOs, so the significances are valid. The additional comparisons in crosses 1 and 2 were unplanned post hoc comparisons, so the significances should be viewed with caution. For cross 4, the data were also analyzed by three-way ANOVA.
b
Means of litter means from two-way ANOVA.
the DXMit16 microsatellite (lying within the inversion) that is polymorphic between C3H/He (86 base pairs [bp]) and MF1 (118 bp). 2. Y long arm. Y-bearing males and females in cross 4 were identified by PCR for a mutiple-copy Y gene family (Ssty, YMT2/B-related subfamily [10, 20] ) located on the long arm of the mouse Y chromosome.
3. Sry transgene. Sry transgene carriers were identified using the transgene-specific primers Tan3Ј and Tan 5Ј [21] .
Placental and Fetal Weights
Females were killed at 17.5 dpc by cervical dislocation. Fetuses with attached placentae were removed into PBS, pH 7.4. The placentae were then detached, fetal membranes were removed, and the fetuses and placentae dried on tissues before being weighed on a pan balance (Oertling, London, UK).
Statistical Analysis
Because there are major litter effects on placental and fetal size, genotype comparisons were made within litters. For the primary analysis, we used two statistical approaches. First, we used the Student t-test to compare an estimate of the difference in placental size and the difference in fetal size between two genotypes, with the calculated SEMs of these estimates. Each estimated difference is a mean weighted difference (MWD) obtained by pooling the information from a series of litters as described previously for X p O fetal and placental weights [3] . For each litter, a weighted difference is calculated for the two genotypes to be compared, the weighting (w ϭ n 1 ϫ n 2 /n 1 ϩ n 2 , where n 1 and n 2 are the genotypes being compared) serving to correct for differences in the number per genotype both within and between litters. The MWD is then calculated by dividing the sum of the weighted differences by the sum of the weights (w). SEMs for these differences are estimated from the variance within genotypes within litters using the appropriate degrees of freedom derived from within genotypes within litters. The MWD divided by the SEM is distributed as t. Second, we used a two-way ANOVA to examine the separate effects of genotype and litter on genotype means. As expected, significant litter effects were seen throughout; there were no significant genotype by litter interactions. The difference between the two approaches is that the comparison of MWDs between genotypes attaches more importance to genotype differences based on larger genotype samples within litters, whereas the comparison of genotype means by ANOVA attaches equal importance to genotype means within litters, irrespective of sample size.
For the data from the XX ϫ XY Ϫ Sry cross (cross 4), the separate effects of litter, sex, and sex chromosome constitution were analysed by three-way ANOVA.
RESULTS
The significances given in the text for the paired genotype comparisons are those for the MWDs. The significances derived from 2-way ANOVA are included in Tables  1 and 2 . There is almost complete concordance with regard to which comparisons are significant, although in most cases the differences for MWDs are significant at a higher level.
X m O and X p O Placentae Are Larger than XX Placentae
Contemporaneous data for X p O placentae were obtained from In(X)/X ϫ XY RIII matings (cross 1) because this cross was used for the previous study that showed that X p O placentae are hyperplastic in late gestation [3] . As a by-product of the present study, we found that a maternally derived copy of the In(X)1H inversion leads to placental hypoplasia in late gestation; thus, for the analysis of the data from this cross we excluded data from inversion carriers. The analysis showed that X p O placentae are significantly larger than XX placentae (MWD ϭ 9.0 Ϯ 3.3 mg, P ϭ 0.012), confirming the previous findings [3] .
We next used the XX ϫ XY* cross (cross 2) to compare X m O placentae with XX placentae. This comparison revealed that X m O placentae are also significantly larger than Fig. 1 XX placentae (MWD ϭ 14.1 Ϯ 3.8 mg, P ϭ 0.003). Because the frequency of X m Os is very low in this cross, we sought to confirm this result using the XX ϫ X Y *O cross (cross 3) to provide a larger sample of X m O placentae. However, all females generated from this cross are X m O, and their placentae can be directly compared only with those of their XX Y * brothers. To enable an indirect comparison of this large sample of X m O placentae with XX placentae, we obtained an estimate of the difference between XX Y * and XX placentae from the XX ϫ XY* cross: XX Y * placentae were estimated to be somewhat smaller than XX placentae (MWD ϭ 4.4 Ϯ 2.1 mg). The indirectly estimated X m O versus XX MWD (19.0 mg) for this large sample of X m O placentae was even greater than that for the XX ϫ XY* cross (14.1 mg), supporting the view that these placentae are hyperplastic. The size of this indirectly estimated MWD in relation to its error suggests that X m O placentae are significantly bigger than X p O placentae (see Fig. 1 ). In an attempt to test this hypothesis, the XX versus X m O MWD from cross 2 was first compared with the indirectly estimated XX versus X m O MWD from cross 3; these two MWDs were not significantly different (t 109 ϭ 1.004, P ϭ 0.318) and were pooled. The new pooled XX versus X m O MWD was then compared with the XX versus X p O MWD from cross 1, and these two MWDs were significantly different (t 131 ϭ 2.667, P ϭ 0.009). Because of the indirect nature of this comparison, this indication that X m O placentae are larger than X p O placentae should be treated with caution. Nevertheless, XO placentae are larger than XX placentae irrespective of the parental origin of the X chromosome. Thus, the previously observed X p O placental hyperplasia in late pregnancy is not a consequence of X p imprinting; rather, it appears to be related to having one rather than two X chromosomes.
Fetal weight data are also presented in Figure 1 . Despite the fact that fetal weights are inherently variable at this stage of pregnancy because of marked effects of position in the uterus, the previously reported reduced fetal weight of X p O but not X m O fetuses [5] is readily apparent.
Other Fetuses with a Single X Genotype Also Have Enlarged Placentae
Because genotyping is carried out subsequent to the collection of the placental and fetal weights, data were available from the In(X)/X ϫ XY RIII (cross 1) and XX ϫ XY* (cross 2) crosses for three other genotypes with a single X X and Y* chromosomes cannot yet be estimated [13] . Pooled estimates of the MWDs with their associated errors are plotted for X m O and XY, but the separate values for the X m O placentae from crosses 2 and 3 are also indicated, as are the separate values for XY RIII from cross 1 and XY Ϫ Ϯ Sry from cross 4. X p O placentae are apparently smaller than X m O placentae, perhaps because the ectoplacental cone (a spongiotrophoblast precursor) is reduced in size at egg cylinder stages [6] . Otherwise, placental size decreases as sex chromosome DNA content increases. The DNA contents of the X and Y chromosomes are based on the estimates of Gregory et al. [31] . The X Y * chromosome is thought to comprise an X and a Y joined end to end with deletion of the distal regions of both PARs [13] and has been given a DNA content equivalent to X ϩ Y. Because the mouse PAR is ϳ0.7 megabases [32] , even if the majority of both PARs are deleted, the plotted value will only be an overestimate by ϳ1 megabase.
chromosome: XY, XY*, and XY* X . Calculation of the MWDs revealed that the placentae of these three genotypes were also larger than XX placentae: XY: MWD ϭ 7.9 Ϯ 2.2 mg (P ϭ 0.001); XY*: MWD ϭ 7.6 Ϯ 2.0 mg (P Ͻ 0.001); X m Y* X : MWD ϭ 8.5 Ϯ 3.3 mg (P ϭ 0.012) (see Fig. 1 ). Although the significances of these additional post hoc comparisons may be questionable, the consistency of the data lends support to the hypothesis of larger placental size for fetuses with a single X chromosome.
Androgen Does Not Increase Placental Size
The problem with using XY and XY* placental weight data as support for an X monosomy effect is that these genotypes are male and are thus producing fetal androgen, which could have an effect on placental size. However, the data from the XX ϫ XY* cross (cross 2) also showed that XY* placentae are markedly larger than XX Y * placentae (MWD ϭ 10.6 Ϯ 2.5 mg, P Ͻ 0.001), which strongly suggests that the X dosage effect outweighs any potential androgen effect. To test directly for an androgen or other gonadal sex effect, we examined placental size in conceptuses from the XX ϫ XY Ϫ Sry cross (cross 4), in which sex is independent of the sex chromosomal complement. We used a three-way ANOVA to asess the separate effects of litter, sex, and sex chromosome complement. No significant effect of sex on placental weights was found, although significant litter effects (P ϭ 0.036) were found, as expected. However, there was a highly significant effect of sex chromosome complement (F 1,17 ϭ 52.54, P ϭ 0.000001). The results for these four genotypes are therefore again consistent with a single X leading to placental hyperplasia; this conclusion is also consistent with the calculated MWD data ( Fig. 1 and Table 1 ). There is therefore no evidence that fetal androgen or any other male gonad dependent factor augments placental size.
The three-way ANOVA of the fetal weight data showed that fetal weight differences in cross 4 are also dependent on sex chromosome complement (F 1,17 ϭ 11.31, P ϭ 0.004) and are independent of sex, indicating that fetal androgen also does not augment fetal size. The fetal weight MWDs ( Fig. 1 and Table 2 ) indicate that XY Ϫ and XY Ϫ Sry fetuses are significantly larger than XX fetuses at 17.5 dpc but XY RIII and XY* fetuses are not. In some strains of Y mice (including the Y Ϫ strain, which is of 129/SvEv-Gpi1 c Y strain origin), fetal size is augmented because of an accelerating effect on cleavage during preimplantation development, whereas in Y RIII mice this acceleration does not occur [4, 22] . The greater size of XY Ϫ and XY Ϫ Sry fetuses at 17.5 dpc may be a consequence of this earlier Y effect.
DISCUSSION
In the present study, we sought confirmation of previous findings suggesting that in late gestation X p O mouse placentae are larger than those of their XX sibs [3] . We also wanted to determine whether X m O placentae are also hyperplastic. The results clearly establish that X m O and X p O placentae are both larger than XX placentae. Nevertheless, the data suggest that X m O placentae may be larger than X p O placentae, which would be consistent with the finding that the ectoplacental cone (a precursor of the spongiotrophoblast of the placenta) is larger in X m O than X p O egg cylinders [6] .
XY placentae are also significantly larger than XX placentae, and this difference is independent of androgen effects. Others previously reported that male placentae were larger than female placentae in interspecific crosses, but no difference between male and female placentae was observed in the control intraspecific C57BL/6 (Mus musculus) cross [23, 24] . However, these authors did not carry out their analysis within litters, as we have done here. The additional data we collected on C57BL/6 placental weight at 17.5 dpc indicate that XY placentae are indeed larger than XX placentae in this cross (XY vs. XX MWD ϭ 8.7 Ϯ 2.3 mg, t 51 ϭ 3.78, P Ͻ 0.001).
Although the possession of one X chromosome rather than two leads to an increase in placental size, the underlying mechanism is still to be determined. A deleterious effect of two PARs is an insufficient explanation because XY placentae are clearly larger than XX placentae, yet both have two PARs. One possibility is that there are X-linked genes expressed in embryo-derived components of the placenta that escape from the normal X dosage compensation process (which occurs via paternal X inactivation), with increased levels of expression reducing placental size. Although the X chromosome is said to be deficient in placentally expressed genes [25] , a handful of placentally expressed X-linked genes have been identified [26] [27] [28] [29] . Although none of these genes has been individually identified as escaping X inactivation, a recent study has suggested that the X chromosome in trophoblast giant cells of the mouse placenta may not be subject to paternal X inactivation, so that all X-linked genes in this tissue may be exempt from X dosage compensation [30] .
Closer examination of the placental weight data for the 487 SEX CHROMOSOMES AND PLACENTAL SIZE range of sex chromosome variant genotypes in the present study suggests an alternative explanation for the placental size differences. Although XY placentae are larger than XX placentae, XX Y * placentae, which have an X chromosome and an X-attached Y chromosome [13] , are smaller than XY* placentae and may be smaller than XX placentae, although this possibility needs exploration. These results suggest that increasing amounts of sex chromosome material as a whole, rather than increased X dosage, may lead to reductions in placental size (Fig. 2) . If this is true, the question remains as to whether the inhibitory effects on placental growth are due to an increase in combined expression of X and Y genes. In addition to the PAR gene Sts, a number of X-Y homologous genes (Smcx/Smcy, Dbx/Dby, Eif2s3x/Eif2s3y, and Utx/Uty) in the mouse are thought to be ubiquitously expressed, with the X homologues exempt from X dosage compensation [33] , and thus are candidates for such an overexpression effect. Alternatively, the critical effect of increasing sex chromosome content (or increasing the amount of sex chromosome heterochromatin) could be in extending DNA replication time. In this regard, it may be pertinent that the trophoblast giant cells uniquely undergo multiple rounds of DNA replication without cell division [34] , which could be of importance with respect to placental growth. If an extension of DNA replication time leads to reduced ploidy in the trophoblast giant cells, then a reduction in gene expression in these cells could result, with a consequent overall reduction in placental growth. Further studies are needed to differentiate between these possibilities.
